A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

A nurse has warned about a common Mounjaro ‘mistake’ that can increase people’s risk of deadly organ damage.

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. ... like high blood pressure or high cholesterol. Professor Louis Aronne from Weill Cornell Medicine.

Tirzepatide, or Mounjaro, is an anti-diabetic drug ... 40 who have at least four other health problems linked to obesity, such as type 2 diabetes; high blood pressure; heart disease; and obstructive ...

An injectable weight-loss treatment is now available through primary care across the UK - and general practices across ...

The researchers found that participants who lost at least 35% of their body weight from baseline to week 72 had mean changes of up to –14.2 and –9.2 mm Hg for systolic and diastolic blood ...

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with ...